Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress CTOR Q1 2026 Earnings Deep Losses and Negative Surprise as Company Remains PreRevenue CMI Q1 2026 Earnings EPS Beats Estimates by 897 as Shares Rally Sanmina Q1 2026 Earnings Strong EPS Surge Defies Estimates VOR Q1 2026 Earnings EPS Misses by Substantial Margin Amid Ongoing Pipeline Development CPB Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick